These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 38782077)

  • 1. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.
    Uliana DL; Lisboa JRF; Gomes FV; Grace AA
    Biochem Pharmacol; 2024 Oct; 228():116298. PubMed ID: 38782077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention.
    Gomes FV; Grace AA
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mGlu
    Maksymetz J; Byun NE; Luessen DJ; Li B; Barry RL; Gore JC; Niswender CM; Lindsley CW; Joffe ME; Conn PJ
    Cell Rep; 2021 Nov; 37(5):109950. PubMed ID: 34731619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.
    Chung DW; Fish KN; Lewis DA
    Am J Psychiatry; 2016 Nov; 173(11):1131-1139. PubMed ID: 27444795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia.
    Nguyen R; Morrissey MD; Mahadevan V; Cajanding JD; Woodin MA; Yeomans JS; Takehara-Nishiuchi K; Kim JC
    J Neurosci; 2014 Nov; 34(45):14948-60. PubMed ID: 25378161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interneuron Transcriptional Dysregulation Causes Frequency-Dependent Alterations in the Balance of Inhibition and Excitation in Hippocampus.
    Bartley AF; Lucas EK; Brady LJ; Li Q; Hablitz JJ; Cowell RM; Dobrunz LE
    J Neurosci; 2015 Nov; 35(46):15276-90. PubMed ID: 26586816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.
    Xu MY; Wong AHC
    Acta Pharmacol Sin; 2018 May; 39(5):733-753. PubMed ID: 29565038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of prefrontal parvalbumin interneurons ameliorates working memory deficit even under clinically comparable antipsychotic treatment in a mouse model of schizophrenia.
    Arime Y; Saitoh Y; Ishikawa M; Kamiyoshihara C; Uchida Y; Fujii K; Takao K; Akiyama K; Ohkawa N
    Neuropsychopharmacology; 2024 Mar; 49(4):720-730. PubMed ID: 38049583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Schizophrenia-Related Deletion Leads to KCNQ2-Dependent Abnormal Dopaminergic Modulation of Prefrontal Cortical Interneuron Activity.
    Choi SJ; Mukai J; Kvajo M; Xu B; Diamantopoulou A; Pitychoutis PM; Gou B; Gogos JA; Zhang H
    Cereb Cortex; 2018 Jun; 28(6):2175-2191. PubMed ID: 28525574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine.
    Reynolds GP; Neill JC
    J Psychopharmacol; 2016 Nov; 30(11):1141-1144. PubMed ID: 27624147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Input-specific maturation of NMDAR-mediated transmission onto parvalbumin-expressing interneurons in layers 2/3 of the visual cortex.
    Ferrer C; Hsieh H; Wollmuth LP
    J Neurophysiol; 2018 Dec; 120(6):3063-3076. PubMed ID: 30303753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct excitation of parvalbumin-positive interneurons by M1 muscarinic acetylcholine receptors: roles in cellular excitability, inhibitory transmission and cognition.
    Yi F; Ball J; Stoll KE; Satpute VC; Mitchell SM; Pauli JL; Holloway BB; Johnston AD; Nathanson NM; Deisseroth K; Gerber DJ; Tonegawa S; Lawrence JJ
    J Physiol; 2014 Aug; 592(16):3463-94. PubMed ID: 24879872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction.
    Phensy A; Lindquist KL; Lindquist KA; Bairuty D; Gauba E; Guo L; Tian J; Du H; Kroener S
    J Neurosci; 2020 Aug; 40(32):6121-6132. PubMed ID: 32605939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor-Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK.
    Kotzadimitriou D; Nissen W; Paizs M; Newton K; Harrison PJ; Paulsen O; Lamsa K
    eNeuro; 2018; 5(2):. PubMed ID: 29740596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prefrontal and Hippocampal Parvalbumin Interneurons in Animal Models for Schizophrenia: A Systematic Review and Meta-analysis.
    Santos-Silva T; Dos Santos Fabris D; de Oliveira CL; Guimarães FS; Gomes FV
    Schizophr Bull; 2024 Jan; 50(1):210-223. PubMed ID: 37584417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-138 controls hippocampal interneuron function and short-term memory in mice.
    Daswani R; Gilardi C; Soutschek M; Nanda P; Weiss K; Bicker S; Fiore R; Dieterich C; Germain PL; Winterer J; Schratt G
    Elife; 2022 Mar; 11():. PubMed ID: 35290180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional dysregulation causes altered modulation of inhibition by haloperidol.
    Brady LJ; Bartley AF; Li Q; McMeekin LJ; Hablitz JJ; Cowell RM; Dobrunz LE
    Neuropharmacology; 2016 Dec; 111():304-313. PubMed ID: 27480797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvalbumin fast-spiking interneurons are selectively altered by paediatric traumatic brain injury.
    Nichols J; Bjorklund GR; Newbern J; Anderson T
    J Physiol; 2018 Apr; 596(7):1277-1293. PubMed ID: 29333742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tonic Activation of GluN2C/GluN2D-Containing NMDA Receptors by Ambient Glutamate Facilitates Cortical Interneuron Maturation.
    Hanson E; Armbruster M; Lau LA; Sommer ME; Klaft ZJ; Swanger SA; Traynelis SF; Moss SJ; Noubary F; Chadchankar J; Dulla CG
    J Neurosci; 2019 May; 39(19):3611-3626. PubMed ID: 30846615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvalbumin Interneuron Dysfunction in Neurological Disorders: Focus on Epilepsy and Alzheimer's Disease.
    Leitch B
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.